Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lockhart

Showing results (191-200 of 338) with videos related to

Pageof 34
Sort By:
Plos One|September 11, 2013
Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolatesShawn R Lockhart, Naureen Iqbal, Julie R Harris, et al.
Diagnostic Microbiology and Infectious Disease|April 13, 2012
Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibilityShawn R Lockhart, Naureen Iqbal, Carol B Bolden, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 25, 2022
Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?Paul E Verweij, Maiken C Arendrup, Ana Alastruey-Izquierdo, et al.
Journal of Medical Microbiology|October 30, 2012
Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibilityJ Q Farooqi, K Jabeen, N Saeed, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Environmental Research|October 21, 2017
Molecular characterization of Cryptococcus neoformans and Cryptococcus gattii from environmental sources and genetic comparison with clinical isolates in Apulia, ItalyMaria Teresa Montagna, Antonella De Donno, Giuseppina Caggiano, et al.
Plos One|March 31, 2015
Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillanceAngela Ahlquist Cleveland, Lee H Harrison, Monica M Farley, et al.
Journal of Clinical Microbiology|August 24, 2007
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004Shawn R Lockhart, Murray A Abramson, Susan E Beekmann, et al.
International Journal of Medical Microbiology : IJMM|November 26, 2009
Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosisAli Abdul Lattif, Pranab K Mukherjee, Jyotsna Chandra, et al.
Emerging Infectious Diseases|August 22, 2024
Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United StatesJeremy A W Gold, Kaitlin Benedict, Shawn R Lockhart, et al.
Pageof 34

Showing results (191-200 of 338) with videos related to

Sort By:
Pageof 34
Plos One|September 11, 2013
Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolatesShawn R Lockhart, Naureen Iqbal, Julie R Harris, et al.
Diagnostic Microbiology and Infectious Disease|April 13, 2012
Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibilityShawn R Lockhart, Naureen Iqbal, Carol B Bolden, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 25, 2022
Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?Paul E Verweij, Maiken C Arendrup, Ana Alastruey-Izquierdo, et al.
Journal of Medical Microbiology|October 30, 2012
Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibilityJ Q Farooqi, K Jabeen, N Saeed, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Environmental Research|October 21, 2017
Molecular characterization of Cryptococcus neoformans and Cryptococcus gattii from environmental sources and genetic comparison with clinical isolates in Apulia, ItalyMaria Teresa Montagna, Antonella De Donno, Giuseppina Caggiano, et al.
Plos One|March 31, 2015
Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillanceAngela Ahlquist Cleveland, Lee H Harrison, Monica M Farley, et al.
Journal of Clinical Microbiology|August 24, 2007
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004Shawn R Lockhart, Murray A Abramson, Susan E Beekmann, et al.
International Journal of Medical Microbiology : IJMM|November 26, 2009
Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosisAli Abdul Lattif, Pranab K Mukherjee, Jyotsna Chandra, et al.
Emerging Infectious Diseases|August 22, 2024
Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United StatesJeremy A W Gold, Kaitlin Benedict, Shawn R Lockhart, et al.
Pageof 34